Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 129-134

  Akula, Kiran Kumar ^a   Dhir, Ashish ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

7 NI; Adenosine; Aminoguanidine; L arginine; L NAME; Methylene blue; Pentylenetetrazol; Seizure threshold; Sildenafil; Sodium nitroprusside

Indexed keywords

7 NITROINDAZOLE; ADENOSINE; ADENOSINE RECEPTOR; AMINOGUANIDINE; ARGININE; CYCLIC GMP; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NATRIURETIC PEPTIDE RECEPTOR A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PENTETRAZOLE; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CLONUS; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG INFUSION; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD; SIGNAL TRANSDUCTION; TENDON REFLEX; TONIC CLONIC SEIZURE;

ADENOSINE; ANIMALS; ANTICONVULSANTS; ARGININE; CONVULSANTS; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ENZYME INHIBITORS; GUANIDINES; INDAZOLES; MALE; METHYLENE BLUE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITROPRUSSIDE; PENTYLENETETRAZOLE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SEIZURES; SIGNAL TRANSDUCTION; SULFONES;

EID: 44149120245     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.03.038     Document Type: Article

References (38)

1. Akula K.K., Dhir A., Bishnoi M., and Kulkarni S.K. Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice. Neurosci. Lett. 425 (2007) 39-42
2. Akula K.K., Dhir A., and Kulkarni S.K. Systemic administration of adenosine ameliorates pentylenetetrazol-induced chemical kindling and secondary behavioural and biochemical changes in mice. Fundam. Clin. Pharmacol. 21 (2007) 583-594
3. Akula K.K., Dhir A., and Kulkarni S.K. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism. Epilepsy Res. 78 1 (2008) 60-70
4. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11 (2005) 25-36
5. Bredt D.S., Hwang P.M., and Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 (1990) 682-685
6. G-Nitro-l-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72 (1993) 387-395
7. De Mendonça A., Sebastião A.M., and Ribeiro J.A. Adenosine: does it have a neuroprotective role after all?. Brain Res. Rev. 33 (2000) 258-274
8. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411 (1999) 334-350
9. Dragunow M., and Goddard G.V. Adenosine modulation of amygdale kindling. Exp. Neurobiol. 84 (1984) 654-665
10. Dunwiddie T.V., and Worth T. Sedative and anticonvulsant effects of adenosine analogs in mice and rats. J. Pharmacol. Exp. Ther. 220 (1982) 70-76
11. Fallahi N., Broad R.M., Jin S., and Fredholm B.B. Release of adenosine from rat hippocampal slices by nitric oxide donors. J. Neurochem. 67 (1996) 186-193
12. Fischer H., Prast H., and Philipp A. Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. Eur. J. Pharmacol. 275 (1995) R5-R6
13. George B., and Kulkarni S.K. Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents. Methods Find. Exp. Clin. Pharmacol. 19 (1997) 329-333
14. Gerevich G., Wirkner K., and Illes P. Adenosine A2A receptors inhibit the N-Nmethyl-d-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur. J. Pharmacol. 451 (2002) 161-164
15. Gulati K., Ray A., and Vijayan V.K. Free radicals and theophylline neurotoxicity: an experimental study. Cell Mol. Biol. (Noisy-le-grand) 53 (2007) 42-52
16. Gupta R.C., and Dettbarn W.D. Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions. Brain Res. 981 (2003) 184-192
17. Hoexter M.Q., Rosa P.S., Tufik S., and Mello L.E. Consequences of prolonged caffeine administration and its withdrawal on pilocarpine- and kainate-induced seizures in rats. Epilepsia 46 (2005) 1401-1406
18. Kaster M.P., Ferreira P.K., Santos A.R., and Rodrigues A.L. Effect of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain. Res. 165 (2005) 204-209
19. Kaster M.P., Rosa A.O., Santos A.R., and Rodrigues A.L. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 8 (2005) 601-606
20. Kulkarni S.K., and Dhir A. Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur. J. Pharmacol. 569 (2007) 77-83
21. Kulkarni S.K., and Patil C.S. Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find. Exp. Clin. Pharmacol. 26 (2004) 789-799
22. Löscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
23. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
24. Nickels T.J., Reed G.W., Drummond J.T., Blevins D.E., Lutz M.C., and Wilson D.F. Does nitric oxide modulate transmitter release at the mammalian neuromuscular junction?. Clin. Exp. Pharmacol. Physiol. 34 (2007) 318-326
25. Noh H.S., Kim D.W., Cho G.J., Choi W.S., and Kang S.S. Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice. Brain Res. 1075 (2006) 193-200
26. Rajasekaran K., Reddy P.L., and Paul V. Effect of systemically administered nitric oxide donor, sodium nitroprusside on picrotoxin-induced convulsions in rats. Indian J. Physiol. Pharmacol. 45 (2001) 95-100
27. Riazi K., Roshanpour M., Rafiei-Tabatabaei N., Homayoun H., Ebrahimi F., and Dehpour A.R. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br. J. Pharmacol. 147 (2006) 935-943
28. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Fiorenza N.G., de Carvalho Myskiw J., Frussa-Filho R., and Mello C.F. Involvement of NO in the convulsive behavior and oxidative damage induced by the intrastriatal injection of methylmalonate. Neurosci. Lett. 376 (2005) 116-120
29. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Fiorenza N.G., Petry J.C., Coelho R.C., and Mello C.F. The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: an electroencephalographic and neurochemical study. Epilepsy Res. 73 (2007) 228-237
30. Thorat S.N., and Kulkarni S.K. The protective effect of adenosinergic agents, Ro 5-4864 and carbamazepine against hypoxic stress-induced neurotoxicity in mice. Methods Find. Exp. Clin. Pharmacol. 12 (1990) 17-22
31. Timóteo M.A., Oliveira L., Campesatto-Mella E., Barroso A., Silva C., Magalhães-Cardoso M.T., Alves-do-Prado W., and Correia-de-Sá P. Tuning adenosine A(1) and A(2A) receptors activation mediates l-citrulline-induced inhibition of [(3)H]-acetylcholine release depending on nerve stimulation pattern. Neurochem. Int. 52 (2008) 834-845
32. Van Leeuwen R., De Vries R., and Dzoljic M.R. 7-Nitroindazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur. J. Pharmacol. 287 (1995) 211-213
33. Wang Q., Theard M.A., Pelligrino D.A., Baughman V.L., Hoffman W.E., Albrecht R.F., Cwik M., et al. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res. 658 (1994) 192-198
34. Wojtal K., Gniatkowska-Nowakowska A., and Czuczwar S.J. Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs?. Pol. J. Pharmacol. 55 (2003) 535-542
35. Yada T., Hiramatsu O., Tachibana H., Toyota E., and Kajiya F. Role of NO and K(+)(ATP) channels in adenosine-induced vasodilation on in vivo canine subendocardial arterioles. Am. J. Physiol. 277 (1999) H1931-H1939
36. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., and Dehpour A.R. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res. 68 (2006) 103-113
37. Yildirim M., and Marangoz C. Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats. Brain Res. 1127 (2007) 193-200
38. Yoshida T., Waeber C., Huang Z., and Moskowitz M.A. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci. Lett. 194 (1995) 214-218